Oura Ring
The platform uses wearable biometric data and clinician-reviewed medical research to provide guidance on menstrual-, pregnancy- and menopause-related health.
Carrot’s Sprints members will have access to sleep, stress, activity and glucose data from Oura and Dexcom, along with clinical guidance to support metabolic fertility care.
The company's CEO, Tom Hale, told MobiHealthNews Oura will use the funds "for AI-driven innovation to redefine what digital health technology can do."
The company anticipates doubling its revenue this year reaching $1 billion in sales.
The ring maker will open a manufacturing facility in Fort Worth, Texas, to support its largest enterprise customer.
The partnership will allow Oura Ring wearers to share their biometric data with the virtual women's health company's care teams.
The announcement comes less than a year after Dexcom announced a strategic partnership and $75 million investment in the health-tracking ring maker.
The company touts that it recently surpassed 2.5 million rings sold and has seen its member base and revenue more than double over the past year.
The investment brings Oura's valuation to more than $5 billion. The partnership enables a two-way data flow between the Oura Ring and Dexcom's continuous glucose monitor.
The acquisition of data company Sparta Science will allow Oura to expand its data analytics capabilities and its B2B offerings.